Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report

Mohammadi, Susan; Abouzaripour, Morteza; Shariati, Nastaran Hesam; Shariati, Mohammad

doi:10.1007/s11239-020-02177-6

Cited by 44 publications

(52 citation statements)

References 20 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In another case report, a patient with COVID‐19 whose complaint was acute abdominal pain diagnosed and revealed ovarian vein thrombosis. Although it develops in a female patient, but this case was significance in terms of genital involvement and it might explained to testicular pain how to occurs by vascular mechanisms 25 . However, pain control was better in our patients of which group 2.…”

Section: Discussionmentioning

confidence: 50%

Is there any association of COVID‐19 with testicular pain and epididymo‐orchitis?

Ediz¹,

Tavukçu²,

Akan³

et al. 2020

Int J Clin Pract

View full text Add to dashboard Cite

Aims This study aims to analyse the novel Coronavirus disease‐ (COVID‐19) related testicular pain in hospitalised patients because of COVID‐19 and to review as an aetiological factor for epididymitis, orchitis or both. Methods A total of 91 patients were included in the study. A questionnaire was formed for the questioning of testicular pain or epididymo‐orchitis in patients with COVID‐19. Demographics and past medical history was also recorded. Patients’ neutrophil and lymphocyte counts, neutrophil‐lymphocyte ratios (NLR), C‐reactive protein (CRP) levels and D‐dimer values were recorded. Patients with COVID‐19 were divided into two groups according to absence or presence of testicular pain or epididymo‐orchitis as group 1 and group 2. All results were compared for both groups. Results The median age of patients was similar in both groups. Testicular pain was occurred in 10.98% of the patients. Clinical presentation of epididymo‐orchitis was diagnosed in only one patient. No statistically significant difference was reported in terms of patients’ age, levels of CRP and D‐Dimer or NLR and results of questionnaire form queries between the two groups (P > .05). Conclusion Testicular pain was observed more frequently in hospitalised COVID‐19 cases. While no inflammation marker which is related to predict of testicular pain or epididymo‐orchitis was found in patients with COVID‐19.

show abstract

Section: Discussionmentioning

confidence: 50%

Is there any association of COVID‐19 with testicular pain and epididymo‐orchitis?

Ediz¹,

Tavukçu²,

Akan³

et al. 2020

Int J Clin Pract

View full text Add to dashboard Cite

show abstract

“…All were case reports. 8,[27][28][29] Coagulopathy or thrombotic complications were reported in these studies. Outcome data were available for at least 90% of patients.…”

Section: Covid -19 Coag Ulopathie S In Preg Nan C Ymentioning

confidence: 83%

“…Based on our search, only four publications relevant to COVID‐19 coagulopathy in pregnancy were identified . All were case reports 8,27‐29 . Coagulopathy or thrombotic complications were reported in these studies.…”

Section: Covid‐19 Coagulopathies In Pregnancymentioning

confidence: 97%

“…Three other case reports highlight the prothrombotic risk of COVID‐19, in young pregnant women admitted with COVID‐19 infection, without personal or family history of thrombosis 27‐29 . The first of these cases highlighted the course of a woman with elevated body mass index (BMI) who developed a segmental pulmonary embolism during the course of her COVID‐19 illness, 27 the second described a woman who presented with abdominal pain and vomiting, was found to be positive for SARS‐CoV‐2, and was eventually diagnosed with ovarian vein thrombosis 29 . The third case report presented COVID‐19 illness during pregnancy in a young woman with a BMI of 35 kg/m 2 and poorly controlled Type 2 diabetes mellitus, which was complicated by basilar artery stroke, pulmonary embolism, and maternal mortality 28 .…”

Section: Covid‐19 Coagulopathies In Pregnancymentioning

confidence: 99%

See 1 more Smart Citation

COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health

Kadir

Kobayashi

Iba

et al. 2020

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

Background: Novel coronavirus (SARS-CoV-2), which causes COVID-19, has thus far affected more than 15 million individuals, resulting in more than 600 000 deaths worldwide, and the number continues to rise. In a large systematic review and metaanalysis of the literature including 2567 pregnant women, 7% required intensive care admission, with a maternal mortality ~1% and perinatal mortality below 1%. There has been a rapid increase in publications on COVID-19-associated coagulopathy, including disseminated intravascular coagulopathy and venous thromboembolism, in the non-pregnant population, but very few reports of COVID-19 coagulopathy during pregnancy; leaving us with no guidance for care of this specific population. Methods: This is a collaborative effort conducted by a group of experts that was reviewed, critiqued, and approved by the International Society on Thrombosis and Haemostasis Subcommittee for Women's Health Issues in Thrombosis and Hemostasis. A structured literature search was conducted, and the quality of current and emerging evidence was evaluated. Based on the published studies in the non-pregnant and pregnant population with a moderate to high risk of bias as assessed by Newcastle-Ottawa scale and acknowledging the absence of data from randomized clinical trials for management of pregnant women infected with SARS-CoV-2, a consensus in support of a guidance document for COVID-19 coagulopathy in pregnancy was identified. Results and Conclusions: Specific hemostatic issues during pregnancy were highlighted, and preliminary recommendations to assist in the care of COVID-19-affected pregnant women with coagulopathy or thrombotic complications were developed. An international registry to gather data to support the management of COVID-19 and associated coagulopathy in pregnancy was established. K E Y W O R D S COVID-19 , COVID-19 pregnancy registry, pregnancy and coagulopathy, pregnancy and venous thromboembolism, thromboprophylaxis in pregnancy | 3087 KADIR et Al.

show abstract

“…Only one case of ovarian venous thrombosis (OVT) has been reported in a pregnant woman after infection with coronavirus with no evidence of venous thrombosis history in her previous deliveries or medical history [13].…”

Section: Discussionmentioning

confidence: 99%

Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports

Merzouk

Harras

Bensahi

et al. 2021

J Thromb Thrombolysis

View full text Add to dashboard Cite

Coronavirus is a source of deep venous thrombosis (DVT) due to complications such as over-coagulation, blood stasis, and endothelial damage. Ovarian vein thrombosis (OVT) is a very serious and rare disease. In this study, we report tow rare case of women with coronavirus who were hospitalized with a right ovarian vein thrombosis mimicking acute abdomen who progressed well on anticoagulation. Our report adds further document in Side effects and rare localisation of obstruction of veins and arteries in patient with corona virus.

show abstract

Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report

Cited by 44 publications

References 20 publications

Is there any association of COVID‐19 with testicular pain and epididymo‐orchitis?

Is there any association of COVID‐19 with testicular pain and epididymo‐orchitis?

COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health

Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports

Contact Info

Product

Resources

About